Finance

Lists
MREO:NASDAQ
Mereo BioPharma Group plc - ADR
US$ ०.३८
-०.३२%
(-०.००१२) 1D
अक्टोबर ५, १४:३६:३२ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MREO...
Open
US$ ०.३७
High
US$ ०.३९
Low
US$ ०.३६
Mkt. cap
६.०४ करोड
Avg. vol.
१६.८८ लाख
Volume
१६.०३ लाख
52-wk high
US$ २.३७
52-wk low
US$ ०.२०
EPS
-US$ ०.१८
Beta
०.१४
Shares outstanding
१५.९७ करोड
No. of employees
३९
Open
US$ ०.३७
High
US$ ०.३९
Low
US$ ०.३६
Mkt. cap
६.०४ करोड
Avg. vol.
१६.८८ लाख
Volume
१६.०३ लाख
52-wk high
US$ २.३७
52-wk low
US$ ०.२०
EPS
-US$ ०.१८
Beta
०.१४
Shares outstanding
१५.९७ करोड
No. of employees
३९
News stories
From web sources and news partners
About Mereo BioPharma Group plc - ADR
CEODenise Scots-Knight
Employees३९
Founded२०१५
Headquarters-
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to MREO in the past 3 months
Hold
Buy
2
Hold
1
Sell
1
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for MREO in the last 3 months.
Highest
Current US$ ०.३८
US$ ३.०० (+६९२.३९%)
Average
US$ ३.०० (+६९२.३९%)
Lowest
US$ ३.०० (+६९२.३९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
US$ ३.००
+६९२.४%
09/17/2026
Priyanka Grover
J.P. Morgan
Sell
Reiterated
-
-
09/15/2026
Kate Dellorusso
LifeSci Capital
Hold
Maintained
-
-
08/15/2026
Gil Blum
Needham
Buy
Maintained
US$ ३.००
+६९२.४%
08/11/2026
Julian Harrison
BTIG
Buy
Maintained
US$ १.००
+१६४.१%
03/19/2026
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
३८.२४ लाख
३७.२० लाख
४६.५२ लाख
१६.८९ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६०.४५ लाख
४१.९७ लाख
४०.१९ लाख
५२.२२ लाख
Operating expense
९८.६९ लाख
७६.१७ लाख
८६.७१ लाख
६९.११ लाख
Total operating expenses
९८.६९ लाख
७६.१७ लाख
८६.७१ लाख
६९.११ लाख
Operating income
-९८.६९ लाख
-७६.१७ लाख
-८६.७१ लाख
-६९.११ लाख
Other non operating income
४.९६ लाख
-६.०० हजार
१७.०० हजार
६.०० हजार
EBT including unusual items
-७०.२४ लाख
-७३.५१ लाख
-६७.१९ लाख
-७०.०५ लाख
EBT excluding unusual items
-७०.२४ लाख
-७३.५१ लाख
-६७.१९ लाख
-७०.०५ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-३.०० लाख
-
-
Net income
-७०.२४ लाख
-७३.५१ लाख
-६७.१९ लाख
-७०.०५ लाख
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
५.०४ लाख
४.२१ लाख
३.२७ लाख
२.७८ लाख
Interest expense
-२८.०० हजार
-२३.०० हजार
-२०.०० हजार
-१६.०० हजार
Net interest expenses
४.७६ लाख
३.९८ लाख
३.०७ लाख
२.६२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-९८.१५ लाख
-७१.५७ लाख
-८५.०० लाख
-६७.४६ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू